References
- Anoopkumar-Dukie S, Conere T, Carey JB, Allshire A. (2005). Radical mediators and mitogen-activated protein kinase signaling in oxygen-dependent radiosensitivity of human tumor cell lines. Free Rad Biol Med 39:188–94.
- Carter SK, Slavik M. (1974). Chemotherapy of cancer. Ann Rev Pharmacol 14:157–83.
- Fleury C, Mignotte B, Vayssiere JL. (2002). Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84:131–41.
- Hall S, Desbrow B, Anoopkumar-Dukie S, et al. (2015). A review of the bioactivity of coffee, caffeine and key coffee constituents on inflammatory responses linked to depression. Food Res Int 76:626–36.
- Hall S, Rudrawar S, Zunk M, et al. (2016). Protection against radiotherapy-induced toxicity. Antioxidants 5:22.
- Hayashi M, Tsuchiya H, Yamamoto N, et al. (2005). Caffeine-potentiated chemotherapy for metastatic carcinoma and lymphoma of bone and soft tissue. Anticancer Res 25:2399–405.
- Jantas D, Pytel M, Mozrzymas J, et al. (2008). The attenuating effect of memantine on staurosporine-, salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem Int 52:864–77.
- Kang S-H, Chess-Williams R, Anoopkumar-Dukie S, Mcdermott C. (2013). Induction of inflammatory cytokines and alteration of urothelial ATP, acetylcholine and prostaglandin E2 release by doxorubicin. Eur J Pharmacol 700:102–9.
- Karita M, Tsuchiya H, Yamamoto N, et al. (2013). Caffeine-potentiated chemotherapy for clear cell sarcoma: a report of five cases. Int J Clin Oncol 18:33–7.
- Kawahara M, Takahashi Y, Takazawa K, et al. (2008). Caffeine dose-dependently potentiates the antitumor effect of cisplatin on osteosarcomas. Anticancer Res 28:1681–5.
- Kim HG, Hwang YP, Jeong HG. (2009). Kahweol blocks STAT3 phosphorylation and induces apoptosis in human lung adenocarcinoma A549 cells. Toxicol Lett 187:28–34.
- Kivisto KT, Kroemer HK, Eichelbaum M. (1995). The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions. Br J Clin Pharmacol 40:523–30.
- Kreahling JM, Foroutan P, Reed D, et al. (2013). Wee1 inhibition by MK-1775 leads to tumor inhibition and enhances efficacy of gemcitabine in human sarcomas. PLoS One 8:e57523.
- Lara DR. (2010). Caffeine, mental health, and psychiatric disorders. J Alzheimers Dis 20:S239–S48.
- Masood I, Kiani MH, Ahmad M, et al. (2015). Major contributions towards finding a cure for cancer through chemotherapy: a historical review. Tumori 102:6–17.
- Mhaidat NM, Alzoubi KH, Al-Azzam SI, Alsaad AA. (2014). Caffeine inhibits paclitaxel-induced apoptosis in colorectal cancer cells through the upregulation of Mcl-1 levels. Mol Med Rep 9:243–8.
- Min SH, Goldman ID, Zhao R. (2008). Caffeine markedly sensitizes human mesothelioma cell lines to pemetrexed. Cancer Chemother Pharmacol 61:819–27.
- Miwa S, Yano S, Tome Y, et al. (2013). Dynamic color‐coded fluorescence imaging of the cell‐cycle phase, mitosis, and apoptosis demonstrates how caffeine modulates cisplatinum efficacy. J Cell Biochem 114:2454–60.
- Muenchen HJ, Quigley MM, Pilat MJ, et al. (2000). The study of gemcitabine in combination with other chemotherapeutic agents as an effective treatment for prostate cancer. Anticancer Res 20:735–40.
- Nicolini G, Rigolio R, Miloso M, et al. (2001). Anti-apoptotic effect of trans-resveratrol on paclitaxel-induced apoptosis in the human neuroblastoma SH-SY5Y cell line. Neurosci Lett 302:41–4.
- Noguchi K, Matsuzaki T, Sakanashi M, et al. (2015). Effect of caffeine contained in a cup of coffee on microvascular function in healthy subjects. J Pharmacol Sci 127:217–22.
- Petru E, Boike G, Sevin B. (1990). Potentiation of cisplatin cytotoxicity by methylxanthines in vitro. J Cancer Res Clin Oncol 116:431–3.
- Ruiz-Crespo S, Trejo-Gabriel-Galan JM, Cavia-Saiz M, Muñiz P. (2012). Coffee component 3-caffeoylquinic acid increases antioxidant capacity but not polyphenol content in experimental cerebral infarction. Neurochem Res 37:1085–90.
- Russo M, Spagnuolo C, Tedesco I, Russo GL. (2010). Phytochemicals in cancer prevention and therapy: truth or dare? Toxins (Basel) 2:517–51.
- Szliszka E, Bronikowska J, Majcher A, et al. (2009). Enhanced sensitivity of hormone-refractory prostate cancer cells to tumour necrosis factor-reIated apoptosis-inducing ligand (TRAIL) mediated cytotoxicity by taxanes. Central Eur J Urol 62:29–34.
- Takeda A, Tsuchiya H, Tajino T, Kikuchi S-I. (2005). An experimental study on the therapeutic effect of consecutive low-dose cisplatin with caffeine in sarcoma-bearing mice. Anticancer Res 25:2777–84.
- Tolba MF, Esmat A, Al-Abd AM, et al. (2013). Caffeic acid phenethyl ester synergistically enhances docetaxel and paclitaxel cytotoxicity in prostate cancer cells. IUBMB Life 65:716–29.
- White SJ, Kasman LM, Kelly MM, et al. (2007). Doxorubicin generates a pro-apoptotic phenotype by phosphorylation of EF-2. Free Rad Biol Med 43:1313–21.